Annual SG&A
$22.91 M
-$1.23 M-5.08%
31 December 2023
Summary:
Assembly Biosciences annual selling, general & administrative expenses is currently $22.91 million, with the most recent change of -$1.23 million (-5.08%) on 31 December 2023. During the last 3 years, it has fallen by -$14.15 million (-38.18%). ASMB annual SG&A is now -38.18% below its all-time high of $37.06 million, reached on 31 December 2020.ASMB Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$4.29 M
-$191.00 K-4.27%
30 September 2024
Summary:
Assembly Biosciences quarterly selling, general & administrative expenses is currently $4.29 million, with the most recent change of -$191.00 thousand (-4.27%) on 30 September 2024. Over the past year, it has increased by +$62.00 thousand (+1.47%). ASMB quarterly SG&A is now -65.83% below its all-time high of $12.54 million, reached on 30 June 2018.ASMB Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$3.20 B
-$40.80 M-1.29%
30 September 2024
Summary:
Assembly Biosciences TTM selling, general & administrative expenses is currently -$3.20 billion, with the most recent change of -$40.80 million (-1.29%) on 30 September 2024. Over the past year, it has dropped by -$3.22 billion (-15853.91%). ASMB TTM SG&A is now -17795.35% below its all-time high of $40.72 million, reached on 30 September 2020.ASMB TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ASMB Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -5.1% | +1.5% | -10000.0% |
| 3 y3 years | -38.2% | -35.6% | -10000.0% |
| 5 y5 years | -34.2% | -49.5% | -10000.0% |
ASMB Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -38.2% | at low | -50.8% | +1.5% | -48.7% | at low |
| 5 y | 5 years | -38.2% | at low | -63.3% | +1.5% | -112.0% | at low |
| alltime | all time | -38.2% | +5667.6% | -65.8% | >+9999.0% | <-9999.0% | at low |
Assembly Biosciences Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $4.29 M(-4.3%) | $22.11 M(+0.3%) |
| June 2024 | - | $4.48 M(-3.4%) | $22.04 M(-2.2%) |
| Mar 2024 | - | $4.63 M(-46.8%) | $22.53 M(-1.6%) |
| Dec 2023 | $22.91 M(-5.1%) | $8.71 M(+106.2%) | $22.91 M(+12.7%) |
| Sept 2023 | - | $4.22 M(-14.9%) | $20.33 M(-4.9%) |
| June 2023 | - | $4.96 M(-0.9%) | $21.37 M(-7.8%) |
| Mar 2023 | - | $5.01 M(-18.2%) | $23.19 M(-3.9%) |
| Dec 2022 | $24.13 M(-16.1%) | $6.13 M(+16.2%) | $24.13 M(-1.5%) |
| Sept 2022 | - | $5.27 M(-22.3%) | $24.51 M(-5.3%) |
| June 2022 | - | $6.78 M(+13.8%) | $25.90 M(-0.5%) |
| Mar 2022 | - | $5.96 M(-8.4%) | $26.03 M(-9.5%) |
| Dec 2021 | $28.78 M(-22.3%) | $6.50 M(-2.3%) | $28.78 M(-2.3%) |
| Sept 2021 | - | $6.66 M(-3.8%) | $29.45 M(-14.6%) |
| June 2021 | - | $6.92 M(-20.5%) | $34.48 M(-6.9%) |
| Mar 2021 | - | $8.70 M(+21.4%) | $37.03 M(-0.1%) |
| Dec 2020 | $37.06 M(+12.6%) | $7.17 M(-38.7%) | $37.06 M(-9.0%) |
| Sept 2020 | - | $11.69 M(+23.4%) | $40.72 M(+8.5%) |
| June 2020 | - | $9.47 M(+8.5%) | $37.52 M(+16.8%) |
| Mar 2020 | - | $8.73 M(-19.4%) | $32.13 M(-2.4%) |
| Dec 2019 | $32.92 M(-5.4%) | $10.83 M(+27.6%) | $32.92 M(+6.6%) |
| Sept 2019 | - | $8.49 M(+108.0%) | $30.89 M(+2.4%) |
| June 2019 | - | $4.08 M(-57.1%) | $30.16 M(-21.9%) |
| Mar 2019 | - | $9.52 M(+8.1%) | $38.62 M(+11.0%) |
| Dec 2018 | $34.80 M(+104.4%) | $8.81 M(+13.6%) | $34.80 M(+12.3%) |
| Sept 2018 | - | $7.75 M(-38.2%) | $30.99 M(+13.0%) |
| June 2018 | - | $12.54 M(+120.2%) | $27.42 M(+46.8%) |
| Mar 2018 | - | $5.70 M(+14.0%) | $18.68 M(+9.7%) |
| Dec 2017 | $17.02 M(+39.7%) | $5.00 M(+19.6%) | $17.02 M(+11.5%) |
| Sept 2017 | - | $4.18 M(+10.0%) | $15.27 M(+9.6%) |
| June 2017 | - | $3.80 M(-5.9%) | $13.93 M(+6.6%) |
| Mar 2017 | - | $4.04 M(+24.5%) | $13.07 M(+7.2%) |
| Dec 2016 | $12.19 M | $3.25 M(+14.0%) | $12.19 M(+2.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2016 | - | $2.85 M(-3.0%) | $11.89 M(+3.1%) |
| June 2016 | - | $2.94 M(-7.1%) | $11.54 M(+4.0%) |
| Mar 2016 | - | $3.16 M(+7.0%) | $11.09 M(-1.9%) |
| Dec 2015 | $11.30 M(-14.7%) | $2.95 M(+18.4%) | $11.30 M(-3.1%) |
| Sept 2015 | - | $2.49 M(+0.2%) | $11.66 M(-29.6%) |
| June 2015 | - | $2.49 M(-26.2%) | $16.55 M(+7.0%) |
| Mar 2015 | - | $3.37 M(+1.8%) | $15.47 M(+16.9%) |
| Dec 2014 | $13.24 M(+189.3%) | $3.31 M(-55.2%) | $13.24 M(+21.8%) |
| Sept 2014 | - | $7.38 M(+423.5%) | $10.87 M(+133.1%) |
| June 2014 | - | $1.41 M(+24.1%) | $4.66 M(+2.4%) |
| Mar 2014 | - | $1.14 M(+21.4%) | $4.55 M(-0.5%) |
| Dec 2013 | $4.58 M(-14.3%) | $935.80 K(-20.7%) | $4.58 M(-3.0%) |
| Sept 2013 | - | $1.18 M(-9.3%) | $4.72 M(-0.1%) |
| June 2013 | - | $1.30 M(+12.1%) | $4.72 M(-0.3%) |
| Mar 2013 | - | $1.16 M(+7.9%) | $4.73 M(-11.4%) |
| Dec 2012 | $5.34 M(-38.8%) | $1.08 M(-9.0%) | $5.34 M(-4.9%) |
| Sept 2012 | - | $1.18 M(-10.2%) | $5.61 M(-11.0%) |
| June 2012 | - | $1.32 M(-25.5%) | $6.31 M(-28.3%) |
| Mar 2012 | - | $1.77 M(+31.1%) | $8.80 M(+0.8%) |
| Dec 2011 | $8.72 M(+199.2%) | $1.35 M(-28.3%) | $8.72 M(-11.0%) |
| Sept 2011 | - | $1.88 M(-50.6%) | $9.80 M(+19.0%) |
| June 2011 | - | $3.80 M(+124.2%) | $8.24 M(+80.1%) |
| Mar 2011 | - | $1.70 M(-30.0%) | $4.58 M(+56.9%) |
| Dec 2010 | $2.92 M(+634.0%) | $2.42 M(+664.2%) | $2.92 M(+330.1%) |
| Sept 2010 | - | $317.10 K(+128.6%) | $677.90 K(+69.1%) |
| June 2010 | - | $138.70 K(+280.0%) | $400.90 K(+42.8%) |
| Mar 2010 | - | $36.50 K(-80.3%) | $280.70 K(-29.3%) |
| Dec 2009 | $397.20 K(-66.5%) | $185.60 K(+362.8%) | $397.30 K(+87.7%) |
| Sept 2009 | - | $40.10 K(+116.8%) | $211.70 K(+23.4%) |
| June 2009 | - | $18.50 K(-87.9%) | $171.60 K(+12.1%) |
| Mar 2009 | - | $153.10 K | $153.10 K |
| Dec 2008 | $1.19 M | - | - |
FAQ
- What is Assembly Biosciences annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Assembly Biosciences?
- What is Assembly Biosciences annual SG&A year-on-year change?
- What is Assembly Biosciences quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Assembly Biosciences?
- What is Assembly Biosciences quarterly SG&A year-on-year change?
- What is Assembly Biosciences TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Assembly Biosciences?
- What is Assembly Biosciences TTM SG&A year-on-year change?
What is Assembly Biosciences annual selling, general & administrative expenses?
The current annual SG&A of ASMB is $22.91 M
What is the all time high annual SG&A for Assembly Biosciences?
Assembly Biosciences all-time high annual selling, general & administrative expenses is $37.06 M
What is Assembly Biosciences annual SG&A year-on-year change?
Over the past year, ASMB annual selling, general & administrative expenses has changed by -$1.23 M (-5.08%)
What is Assembly Biosciences quarterly selling, general & administrative expenses?
The current quarterly SG&A of ASMB is $4.29 M
What is the all time high quarterly SG&A for Assembly Biosciences?
Assembly Biosciences all-time high quarterly selling, general & administrative expenses is $12.54 M
What is Assembly Biosciences quarterly SG&A year-on-year change?
Over the past year, ASMB quarterly selling, general & administrative expenses has changed by +$62.00 K (+1.47%)
What is Assembly Biosciences TTM selling, general & administrative expenses?
The current TTM SG&A of ASMB is -$3.20 B
What is the all time high TTM SG&A for Assembly Biosciences?
Assembly Biosciences all-time high TTM selling, general & administrative expenses is $40.72 M
What is Assembly Biosciences TTM SG&A year-on-year change?
Over the past year, ASMB TTM selling, general & administrative expenses has changed by -$3.22 B (-15853.91%)